{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:45:33Z","timestamp":1774673133171,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jns.2020.117103","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T21:28:59Z","timestamp":1597958939000},"page":"117103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study"],"prefix":"10.1016","volume":"418","author":[{"given":"Vanessa","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Videira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Sam\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernestina","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.117103_bb0005","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117103_bb0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.117103_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jns.2020.117103_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes Francesc","volume":"25","author":"Graus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS euronetwork database","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes: report of an EFNS task force","volume":"13","author":"Vedeler","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes","volume":"253","author":"Shams\u2019ili","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0045","first-page":"732","article-title":"Paraneoplastic neurological syndromes: diagnosis and treatment","volume":"20","author":"Graus","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0050","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1212\/CON.0000000000000542","article-title":"Paraneoplastic disorders","volume":"23","author":"Lancaster","year":"2017","journal-title":"Contin Lifelong Learn Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0055","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","article-title":"Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration","volume":"71","author":"De Graaff","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0060","first-page":"1","article-title":"Article unintended consequences of mayo paraneoplastic evaluations","volume":"00","author":"Ebright","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117103_bb0065","first-page":"1","article-title":"The positive predictive value of Onconeural antibody testing: a retrospective review","volume":"00","author":"Budhram","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117103_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1034\/j.1600-0404.2001.104002072.x","article-title":"Paraneoplastic neurological syndromes - Patients\u2019 cohort profile in the Czech Republic","volume":"104","author":"Tourac","year":"2001","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2020.117103_bb0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00207454.2016.1207644","article-title":"Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort","volume":"127","author":"Albadareen","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jns.2020.117103_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.117103_bb0090","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2020.117103_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01482","article-title":"The diagnostic value of onconeural antibodies depends on how they are tested","volume":"11","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20304408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20304408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:26Z","timestamp":1758383546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20304408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":19,"alternative-id":["S0022510X20304408"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117103","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117103"}}